Fatigue News and Research

RSS
CDK6: a potential drug target for severe COVID-19

CDK6: a potential drug target for severe COVID-19

Exercise elicits benefits to breast cancer patients’ physical and mental health

Exercise elicits benefits to breast cancer patients’ physical and mental health

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Breathlessness and fatigue most common in self reported long-COVID

Breathlessness and fatigue most common in self reported long-COVID

Researchers aim to study the underlying pathophysiology of diastolic heart failure

Researchers aim to study the underlying pathophysiology of diastolic heart failure

Study finds lesser number of female principal investigators in cardiovascular clinical trials

Study finds lesser number of female principal investigators in cardiovascular clinical trials

The relationship between numerous pandemic-related stressors and psychological distress facets in Israel

The relationship between numerous pandemic-related stressors and psychological distress facets in Israel

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

Metabolomic profiling reveals adrenal suppression due to inhaled corticosteroid treatment for asthma

Metabolomic profiling reveals adrenal suppression due to inhaled corticosteroid treatment for asthma

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Safety and antibody responses to COVID-19 vaccines in an older community

Safety and antibody responses to COVID-19 vaccines in an older community

Study explores prevalence and symptom trajectory of long COVID

Study explores prevalence and symptom trajectory of long COVID

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women less likely to receive lifesaving intervention for cardiogenic shock than men

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Prevalence and duration of post-COVID condition in healthcare workers

Prevalence and duration of post-COVID condition in healthcare workers

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.